RMD - Resmed Inc

Insider Sale by Farrell Peter C (Dir)

1 Month
After Trade
Before Trade

Loading data...

Trade Summary

2 days ago, Farrell Peter C, serving as Dir at Resmed Inc (RMD), sold 2,000 shares at $260.22 per share, for a total transaction value of $520,440.00. Following this transaction, Farrell Peter C now holds 62,773 shares of RMD.

This sale represents a 3.00% decrease in Farrell Peter C's stake in the company. This is considered a medium-conviction trade.

The trade was executed on Wednesday, March 4, 2026 and publicly disclosed via SEC Form 4 filing on Thursday, March 5, 2026, 1 day after the trade was made.

Resmed Inc operates in the HEALTHCARE sector, specifically within the MEDICAL INSTRUMENTS & SUPPLIES industry. Insider selling activity in this sector can provide valuable signals about industry trends and company-specific developments.

Farrell Peter C

Dir

Peter C. Farrell, PhD, DSc, AM, is the founder, former long-term CEO, and current Chairman of the Board of Directors at ResMed Inc. (NYSE: RMD), a global leader in sleep-disordered breathing treatments, where he has served as Chairman and Director since the company's inception in 1989 via a management buyout from Baxter Healthcare.[[1]](https://montgomerysummit.com/speakers/peter-farrell/)[[4]](https://immunicom.com/team-member/peter-c-farrel-phd-dsc-am/)[[5]](https://unswfounders.com/biographies/peter-farrell) As a corporate insider and Director, he remains actively involved, having transitioned from CEO/Executive Chairman roles until January 2014 while continuing as a non-officer employee.[[4]](https://immunicom.com/team-member/peter-c-farrel-phd-dsc-am/) Dr. Farrell holds a B.E. in chemical engineering (honors) from the University of Sydney, an S.M. in chemical engineering from MIT, a PhD in bioengineering from the University of Washington, and a DSc from UNSW.[[1]](https://montgomerysummit.com/speakers/peter-farrell/)[[2]](https://www.webmd.com/bio/peter-c-farrell)[[4]](https://immunicom.com/team-member/peter-c-farrel-phd-dsc-am/) His career highlights include prior roles as Vice President of R&D at Baxter Healthcare subsidiaries (1984-1989) and Foundation Director of UNSW's Graduate School for Biomedical Engineering (1978-1989).[[1]](https://montgomerysummit.com/speakers/peter-farrell/)[[4]](https://immunicom.com/team-member/peter-c-farrel-phd-dsc-am/)[[5]](https://unswfounders.com/biographies/peter-farrell) A distinguished leader, he has served on boards including NuVasive (2005-2018), Arcturus Therapeutics (Chairman since 2018), WaveGuide (Chairman), Scripps Research Institute, and advisory councils at MIT, UCSD, and Harvard Medical School's Division of Sleep Medicine (Chairman 2010-2013).[[1]](https://montgomerysummit.com/speakers/peter-farrell/)[[3]](https://sleep.hms.harvard.edu/news-events/hms-division-sleep-medicine-prize/prize-recipients/2013-prize-recipient-peter-c-farrell)[[4]](https://immunicom.com/team-member/peter-c-farrel-phd-dsc-am/) Honors include election to the US National Academy of Engineering (2012), US National Entrepreneur of the Year for Health Sciences (2005), Australian Entrepreneur of the Year (2001), and the 2013 Harvard Peter C. Farrell Prize in Sleep Medicine.[[1]](https://montgomerysummit.com/speakers/peter-farrell/)[[3]](https://sleep.hms.harvard.edu/news-events/hms-division-sleep-medicine-prize/prize-recipients/2013-prize-recipient-peter-c-farrell)[[4]](https://immunicom.com/team-member/peter-c-farrel-phd-dsc-am/)[[5]](https://unswfounders.com/biographies/peter-farrell)

View full insider profile →

Trade Price

$260.22

Quantity

2,000

Total Value

$520,440.00

Shares Owned

62,773

Trade Date

Wednesday, March 4, 2026

2 days ago

SEC Filing Date

Thursday, March 5, 2026

Filed 1 day after trade

HEALTHCAREMEDICAL INSTRUMENTS & SUPPLIES

About Resmed Inc

Company Overview

No company information available
View news mentioning RMD

💬 Want Deeper Insight?

Use our AI assistant to ask questions about this trade, the insider, or the company.

Chat with AI

Share this trade

https://insidersignal.ai/trade/4522551

🚀 Track Insider Trades in Real-Time

Create a free account to access our full database of insider trades, AI-powered analysis, price alerts, and discover what corporate executives are buying and selling.

✓ Free forever plan available  •  ✓ No credit card required  •  ✓ Cancel anytime